Emma Rapaport

Co-editor, Street Talk at Australian Financial Review

Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review. Source

Featured in: Favicon

afr.com

Articles

Cancer therapy biotech Celleo in private fund-raising round

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

Melbourne’s Celleo, a start-up specialising in automated production systems for cell therapies for cancer, has mandated stockbroker Alpine Capital to raise $5 million in a private fund-raising round. A cervical cancer cell. Loading...
ASX listing candidate Campana puts itself back on the agenda

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

There are signs of life at digital infrastructure business Campana, one of 2024’s IPO hopefuls that piggybacked off exploding demand for data centres. Street Talk reported in October that Campana, which operates fibre and cables connecting Asian data centres to clients, told fund managers timing for its $400 million-plus backdoor listing had been pushed back by a couple of months. Loading...
Oaktree in talks to finance Sanjeev Gupta’s Tahmoor coal mine in NSW

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

Distressed debt giant Oaktree Capital Management has discussed financing British-Indian industrialist Sanjeev Gupta’s Tahmoor coal mine in NSW – a sprawling operation that had fed the Whyalla and Port Kembla steelworks before being idled in early February amid financing troubles.
Celeste portfolio manager Martin Byers lands at MA Moelis’ sales desk

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

It hasn’t taken long for Celeste Funds Management portfolio manager Martin Byers to land a new role. Celeste portfolio manager Martin Byers is set to enter MA’s Brookfield Place office. BloombergLoading...
Sonic Healthcare set to lift stake in Microba to 19.9pc

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

The $12.7 billion diagnostics giant Sonic Healthcare is set to lift its stake in biotech Microba Life Sciences to 19.9 per cent, the maximum permissible shareholding allowed in a listed company in absence of a takeover bid, as part of an equity raising. Microba Life Sciences chairman Ian Frazer, CEO Luke Reid and co-founder Gene Tyson at the listing ceremony in April 2022. Loading...
Private equity snaps up Aussie brand Doors Plus

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

Who can forget the iconic 1990s commercial Doors Plus, No Fuss? That jingle and the door retailer’s 22 showrooms and five distribution centres across Australia are set to trade to mid-market private equity firm Colinton Capital Partners.
Bain, IFM tip into ScotPac’s $325m refinancing; Affinity nets dividend

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

ScotPac, which pitches itself as Australia’s largest non-bank lender to businesses, has finalised a $325 million debt refinancing which paves the way for its private equity owner to pay itself a dividend cheque. Street Talk can reveal the invoicing and trade finance business has signed a deal to upsize a loan put in place in 2022, after securing commitments from Bain Capital Credit, IFM Investors and MA Financial. The new facility matures in late 2027. Loading...
Private capital heavyweights circle Ellerston’s $1b NOJA Power

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

Plucky Queensland upstart NOJA Power has morphed into a billion-dollar business with products sold in 114 countries over the past 23 years. Now, it’s the next hot M&A target Down Under for global private equity giants. Neil O’Sullivan of NOJA Power Switchgear. SuppliedLoading...
CLSA shops at MA Moelis for head of sales

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

It’s a homecoming for equity sales operative Sandy Isherwood, who is set to return to CLSA Australia after seven years as its new head of sales. CLSA has a new leadership group in Australia. BloombergLoading...
Goldman Sachs hires head of equity sales from RBC

1 week ago | afr.com | Sarah Thompson |Kanika Sood |Emma Rapaport

Goldman Sachs has poached RBC Capital Markets’ James Cornell as its new head of equity sales. Goldies has made two hires. Dominic LorrimerLoading...